CAMDEN ASSET MANAGEMENT L P /CA - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 34 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
CAMDEN ASSET MANAGEMENT L P /CA ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$24,251,000
-15.4%
27,875,000
-11.2%
0.72%
-9.3%
Q4 2018$28,682,000
+5.6%
31,375,000
+21.3%
0.80%
+4.5%
Q3 2018$27,157,000
+2.8%
25,875,0000.0%0.76%
-12.0%
Q2 2018$26,415,000
+5.2%
25,875,000
+6.2%
0.87%
+7.4%
Q1 2018$25,107,000
+25.2%
24,375,000
+4.3%
0.81%
+4.7%
Q4 2017$20,059,000
-36.3%
23,375,000
-27.8%
0.77%
-25.6%
Q3 2017$31,485,000
+1.7%
32,375,000
+0.3%
1.04%
+10.7%
Q2 2017$30,944,00032,275,0000.94%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Context Capital Management, LLC 8,800,000$9,187,0005.34%
Context Partners Fund, L.P. 8,800,000$9,187,0005.34%
STEELHEAD PARTNERS LLC 49,265,000$51,400,0004.76%
TENOR CAPITAL MANAGEMENT Co., L.P. 40,025,000$42,276,0002.53%
CAMDEN ASSET MANAGEMENT L P /CA 25,875,000$27,157,0000.76%
Telemetry Investments, L.L.C. 1,000,000$1,050,0000.48%
SSI INVESTMENT MANAGEMENT LLC 5,500,000$5,734,0000.44%
AQR Arbitrage LLC 32,975,000$34,691,0000.40%
WOLVERINE ASSET MANAGEMENT LLC 31,474,000$32,853,0000.38%
Opera Trading Capital 1,500,000$1,565,0000.30%
View complete list of AMAG PHARMACEUTICALS INC shareholders